Vandetanib Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 300 mg
Reference Brands: Caprelsa
Category: Orphan Drugs
Vandetanib Tablets is available in Tablets and strengths such as 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vandetanib Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Vandetanib Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Vandetanib tablets, marketed as Caprelsa, are approved in the US by the FDA and in the EU via EMA for treating medullary thyroid carcinoma. Regulatory approval requires a comprehensive dossier, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports rapid approval, safe patient use, and worldwide availability to improve outcomes in advanced thyroid cancer management globally. Mitul agarwal Riluzole: Forms, Brands, and Strengths in EU and US OpenAI GPT-4o mini Riluzole: Forms, Brands, and Strengths in EU and US Forms: Oral Tablets: The primary form for use in amyotrophic lateral sclerosis (ALS). Brands & Strengths: US: Rilutek: (brand name) Strengths: 50 mg tablets EU: Riluzole: (generic and branded options) Strengths: Similar 50 mg tablets Summary: Riluzole is available as 50 mg oral tablets in both the US and EU, supported for slowing ALS progression. Generic formulations and branded Rilutek ensure broad access, supporting disease management in ALS patients worldwide with regional regulatory compliance.
Frequently Asked Questions
Related Products
Galsulfase Iv
Strength:
1mg/ml
Form: Lyophilized powder for IV
Reference Brands: Vimizim®(US & EU)
View Details
Alglucosidase Alfa Iv
Strength:
50 mg/vial
Form: Lyophilized powder
Reference Brands: Lumizyme®(US & EU)
View Details
Treprostinil Iv Or Sc
Strength:
2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)
Form: SC or Intravenous (IV)
Reference Brands: Remodulin®(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
